Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
8 Ergebnisse für "comparison" unter Roche Glycart AG
Elecsys® SCC
... , E.K., Stampfer, M.J., Rosner, B.A., Colditz, G.A. (2008). Comparison of aspects of smoking among the ... Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE. Tumor. Biol.; 29: 371-380. Lozza, L ... ., Colditz, G.A. (2008). Comparison of aspects of smoking among the four histological types of lung cancer ... 19.9, CA 15.3 and TAG-72.4 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1 ...
Модульная система cobas® 4800
... -Summary Report. (April 2015); CT/NG System Comparison Study V4.0 (Dec 2011); HPV System Comparison Study ... . № ФСЗ 2011/09271 Microbiology Project-Summary Report. (April 2015); CT/NG System Comparison Study V4.0 ... (Dec 2011); HPV System Comparison Study. V4.0 (Feb 2011). Oklahoma City, OK: Argent Global Services ...
